Mostrar el registro sencillo del ítem

dc.contributor.authorRuiz Malagón, Antonio Jesús 
dc.contributor.authorRodríguez Sánchez, María José
dc.contributor.authorRodríguez Sojo, María Jesús 
dc.contributor.authorVezza, Teresa
dc.contributor.authorAlgieri, Francesca
dc.contributor.authorRodríguez Cabezas, María Elena 
dc.contributor.authorRodríguez Nogales, Alba 
dc.contributor.authorGálvez Peralta, Julio Juan 
dc.date.accessioned2022-11-28T09:51:49Z
dc.date.available2022-11-28T09:51:49Z
dc.date.issued2022-09-02
dc.identifier.citationRuiz-Malagón AJ... [et al.] (2022), Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats. Front. Pharmacol. 13:967644. doi: [10.3389/fphar.2022.967644]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/78151
dc.description.abstractEthnopharmacological relevance: Serpylli herba extract (SHE), composed of the aerial parts of wild thyme (Thymus serpyllum L.) (Lamiaceae family), is traditionally used in Europe and North Africa to treat diarrhea, gastric ulcers, intestinal parasites and upper respiratory tract infections. Recently, SHE has generated a great interest for irritable bowel syndrome (IBS) management, probably due to its intestinal anti-inflammatory properties shown in experimental colitis and the fact that its active components could preserve the intestinal barrier integrity, which is altered in patients with IBS. Aim of study: We aimed to test the effects of a SHE in a rat experimental model resembling human IBS. Materials and methods: IBS was provoked by deoxycholic acid (DCA). Rats were then treated with SHE (100 mg/kg) or gabapentin (70 mg/kg) and different inflammatory and gut barrier integrity markers were evaluated. Moreover, several gut hypersensitivity and hyperalgesia determinations were performed. Results: SHE improved referred pain and visceral hypersensitivity. Additionally, SHE enhanced immune status by downregulating of the expression of the proinflammatory mediators Il-1β, Il-6, Ifn-γ, Tlr-4, and the inducible enzyme Cox-2, thus inducing visceral analgesia, and promoting the restore of the gut barrier function by upregulating the mucins Muc-2 and Muc-3. These antiinflammatory effects could be related to its action on mast cells since it significantly inhibited the β-Hexosaminidase production in RBL-2H3 cells. Lastly, SHE also seems to modulate the serotonin pathway by restoring the altered expression of the 5-HT receptors Htr-3 and Htr-4. Conclusion: SHE could be considered a potential new treatment for IBS, since it ameliorates hypersensitivity, visceral hyperalgesia, and inflammation. These beneficial effects may be due to the inhibition of mast cells degranulation and serotonin pathway.es_ES
dc.description.sponsorshipJunta de Andalucia AGR6826 CTS 164es_ES
dc.description.sponsorshipSpanish Government SAF 2011-29648es_ES
dc.description.sponsorshipInstituto de Salud Carlos IIIes_ES
dc.description.sponsorshipEuropean Commission PI19/01058 PI20/01447es_ES
dc.language.isoenges_ES
dc.publisherFrontierses_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectSerpylli herbaes_ES
dc.subjectT. serpyllum L.es_ES
dc.subjectIntestine anti inflammatory activityes_ES
dc.subjectVisceral analgesiaes_ES
dc.subjectIBS rat modeles_ES
dc.titleIntestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in ratses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3389/fphar.2022.967644
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional